Staff at the genetic research company deCODE will reportedly keep their jobs following its acquisition by California-based biotechnology group Amgen yesterday. CEO of Amgen told RÚV that the company also planned to hire more staff in Iceland.
Founder and CEO of deCODE Genetics Kári Stefánsson will also keep his position and be appointed vice-president of research at the U.S. company but told Fréttablaðið that: “I am however no spring-chicken anymore and don’t know much longer I will continue on.”
Kári said that what Amgen had essentially purchased “nothing more than our capability, skill and experience to make discoveries.”
DeCODE was founded in Reykjavík in 1996 and is considered a global leader in analyzing and understanding the link between the genome and disease susceptibility.
The company has discovered genetic risk factors for various diseases including cardiovascular disease and cancer.
DeCODE has 130 staff members in Iceland.
Click here to read more about this story.
Click here to learn about our custom made photo book Iceland 2012 with the best pictures of the year.